Allergan Aesthetics has received FDA approval for the Juvederm Voluma XC injectable gel implant to improve moderate to severe temple hollowing in patients age 21 or older. The decision was based on a study that found the gel achieved improvement of at least one point in 80.4% of patients at three months.